Jun Wang

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 63

Top Venues

Journal of medicinal chemistry

bioRxiv : the preprint server for biology

ACS infectious diseases

Physical chemistry chemical physics : PCCP

University of Arizona

University of Pennsylvania (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Arizona Jul 01 2020

United States

Associate Professor :: Pharmacology and Toxicology

University of Arizona Mar 01 2014 - Jun 30 2020

United States

Assistant Professor :: Pharmacology and Toxicology

University of California San Francisco Nov 01 2011 - Mar 01 2014

United States

Postdoctoral Researcher :: Pharmaceutical chemistry

University of Pennsylvania Jan 01 2011 - Oct 31 2011

United States

Postdoctoral Researcher :: Biochemistry and Biophysics

Education History

University of Pennsylvania Jul 01 2006 - Dec 30 2010

United States

PHD :: Chemistry

National University of Singapore Jun 01 2004 - Jun 01 2006

Singapore

MSC :: Chemistry

Wuhan University Sep 01 1999 - Jun 30 2003

China

BSC :: Chemistry

Publications

Yanina Pankratova, Matthew J McKay, Chunlong Ma, Haozhou Tan, Jun Wang, Mei Hong
Structure and dynamics of the proton-selective histidine and the gating tryptophan in an inward rectifying hybrid influenza B and A virus M2 proton channel. Physical chemistry chemical physics : PCCP 26 (30) (2024)
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, Prakash Jadhav, Haozhou Tan, Kan Li, Ashima Chopra, Alexandra Ford, Xiang Chi, Francesc Xavier Ruiz, Eddy Arnold, Xufang Deng, Jun Wang
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science (New York, N.Y.) 383 (6690) (2024)
Yanina Pankratova, Matthew J McKay, Chunlong Ma, Haozhou Tan, Jun Wang, Mei Hong
Structure and dynamics of the proton-selective histidine and the gating tryptophan in an inward rectifying hybrid influenza B and A virus M2 proton channel. Physical chemistry chemical physics : PCCP 26 (30) (2024)
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, Prakash Jadhav, Haozhou Tan, Kan Li, Ashima Chopra, Alexandra Ford, Xiang Chi, Francesc Xavier Ruiz, Eddy Arnold, Xufang Deng, Jun Wang
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science (New York, N.Y.) 383 (6690) (2024)
Yanina Pankratova, Matthew J McKay, Chunlong Ma, Haozhou Tan, Jun Wang, Mei Hong
Structure and dynamics of the proton-selective histidine and the gating tryptophan in an inward rectifying hybrid influenza B and A virus M2 proton channel. Physical chemistry chemical physics : PCCP 26 (30) (2024)
Eric M Lewandowski, Xiujun Zhang, Haozhou Tan, Aiden Jaskolka-Brown, Navita Kohaal, Aliaksandra Frazier, Jesper J Madsen, Lian M C Jacobs, Jun Wang, Yu Chen
Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance. bioRxiv : the preprint server for biology (2024)
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, Prakash Jadhav, Haozhou Tan, Kan Li, Ashima Chopra, Alexandra Ford, Xiang Chi, Francesc Xavier Ruiz, Eddy Arnold, Xufang Deng, Jun Wang
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science (New York, N.Y.) 383 (6690) (2024)
Yanina Pankratova, Matthew J McKay, Chunlong Ma, Haozhou Tan, Jun Wang, Mei Hong
Structure and dynamics of the proton-selective histidine and the gating tryptophan in an inward rectifying hybrid influenza B and A virus M2 proton channel. Physical chemistry chemical physics : PCCP (2024)
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, Prakash Jadhav, Haozhou Tan, Kan Li, Ashima Chopra, Alexandra Ford, Xiang Chi, Francesc Xavier Ruiz, Eddy Arnold, Xufang Deng, Jun Wang
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science (New York, N.Y.) 383 (6690) (2024)
Jun Wang, Md Shahed-Ai-Mahmud, Angelo Chen, Kan Li, Haozhou Tan, Ryan Joyce
An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses. Journal of medicinal chemistry (2023)
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, Prakash Jadhav, Haozhou Tan, Kan Li, Ashima Chopra, Alexandra Ford, Xiang Chi, Francesc Xavier Ruiz, Eddy Arnold, Xufang Deng, Jun Wang
Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. bioRxiv : the preprint server for biology (2023)
Bin Tan, Chang Liu, Kan Li, Prakash Jadhav, George Lamprinidis, Lan Zhu, Linda Olson, Haozhou Tan, Yu Wen, Antonios D Kolocouris, Wei Liu, Jun Wang
Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors. Journal of medicinal chemistry (2023)
Joshua L Frost, Michael J Rudy, J Smith Leser, Haozhou Tan, Yanmei Hu, Jun Wang, Penny Clarke, Kenneth L Tyler
Telaprevir Treatment Reduces Paralysis in a Mouse Model of Enterovirus D68 Acute Flaccid Myelitis. Journal of virology (2023)
Yanmei Hu, Eric M Lewandowski, Haozhou Tan, Xiaoming Zhang, Ryan T Morgan, Xiujun Zhang, Lian M C Jacobs, Shane G Butler, Maura V Gongora, John Choy, Xufang Deng, Yu Chen, Jun Wang
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir. ACS central science 9 (8) (2023)
Michael D Sacco, Shaohui Wang, Swamy R Adapa, Xiujun Zhang, Eric M Lewandowski, Maura Verenice Gongora, Dimitra Keramisanou, Zachary D Atlas, Julia A Townsend, Jean R Gatdula, Ryan T Morgan, Lauren R Hammond, Michael Thomas Marty, Jun Wang, Prahathees J Eswara, Ioannis Gelis, Rays H Y Jiang, Xingmin Sun, Yu Chen
A unique class of Zn 2+ -binding serine-based PBPs underlies cephalosporin resistance and sporogenesis in Clostridioides difficile. Nature communications 13 (1) (2022)
Bin Tan, Ryan Joyce, Haozhou Tan, Yanmei Hu, Jun Wang
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies. Accounts of chemical research 56 (2) (2022)
Haozhou Tan, Yanmei Hu, Prakash Jadhav, Bin Tan, Jun Wang
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease. Journal of medicinal chemistry 65 (11) (2022)
Colin J Potter, Yanmei Hu, Zhen Xiong, Jun Wang, Euan Mcleod
Point-of-care SARS-CoV-2 sensing using lens-free imaging and a deep learning-assisted quantitative agglutination assay. Lab on a chip 22 (19) (2022)
Chunlong Ma, Jun Wang
Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors. ACS pharmacology & translational science 5 (2) (2022)
Michael Dominic Sacco, Yanmei Hu, Maura Verenice Gongora, Flora Meilleur, Michael Trent Kemp, Xiujun Zhang, Jun Wang, Yu Chen
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition. Cell research 32 (5) (2022)
Bin Tan, Ryan Joyce, Haozhou Tan, Yanmei Hu, Jun Wang
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies. Accounts of chemical research 56 (2) (2022)
Haozhou Tan, Chunlong Ma, Jun Wang
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor. Research square (2022)
Bin Tan, Ryan Joyce, Haozhou Tan, Yanmei Hu, Jun Wang
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies. Accounts of chemical research 56 (2) (2022)
Xu Zhou, Lingxiang Zhu, Cheryl Bondy, Jun Wang, Qianwen Luo, Yin Chen
AG1478 Elicits a Novel Anti-Influenza Function via an EGFR-Independent, GBF1-Dependent Pathway. International journal of molecular sciences 23 (10) (2022)
Ryan P Joyce, Vivian W Hu, Jun Wang
The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 31 (10) (2022)
Yanmei Hu, Eric M Lewandowski, Haozhou Tan, Xiaoming Zhang, Ryan T Morgan, Xiujun Zhang, Lian M C Jacobs, Shane G Butler, Maura V Gongora, John Choy, Xufang Deng, Yu Chen, Jun Wang
Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir. bioRxiv : the preprint server for biology (2022)
Bin Tan, Ryan Joyce, Haozhou Tan, Yanmei Hu, Jun Wang
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies. Accounts of chemical research (2022)
Haozhou Tan, Chunlong Ma, Jun Wang
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 31 (7) (2022)
Kimberly Gomez, Cheng Tang, Bin Tan, Samantha Perez-Miller, Dongzhi Ran, Santiago Loya, Aida Calderon-Rivera, Harrison J Stratton, Paz Duran, Kyleigh A Masterson, Anna T Gabrielsen, Omar Alsbiei, Angie Dorame, Maria Serafini, Aubin Moutal, Jun Wang, Rajesh Khanna
Stereospecific Effects of Benzimidazolonepiperidine Compounds on T-Type Ca 2+ Channels and Pain. ACS chemical neuroscience 13 (13) (2022)
Yanmei Hu, Hyunil Jo, William F DeGrado, Jun Wang
Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell. Journal of medical virology 94 (5) (2022)
Chunlong Ma, Yanmei Hu, Yuyin Wang, Juliana Choza, Jun Wang
Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor. ACS infectious diseases 8 (5) (2022)
Jin Ou, Eric Lewandowski, Yanmei Hu, Austin Lipinski, Ryan T Morgan, Lian Jacobs, Xiujun Zhang, Melissa J Bikowitz, Paul Langlais, Haozhou Tan, Jun Wang, Yu Chen, John Choy
A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations. Research square (2022)
Zilei Xia, Michael Sacco, Yanmei Hu, Chunlong Ma, Xiangzhi Meng, Fushun Zhang, Tommy Szeto, Yan Xiang, Yu Chen, Jun Wang
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir. ACS pharmacology & translational science 4 (4) (2021)
Chunlong Ma, Zilei Xia, Michael Dominic Sacco, Yanmei Hu, Julia Alma Townsend, Xiangzhi Meng, Juliana Choza, Haozhou Tan, Janice Jang, Maura V Gongora, Xiujun Zhang, Fushun Zhang, Yan Xiang, Michael Thomas Marty, Yu Chen, Jun Wang
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity. Journal of the American Chemical Society (2021)
Chunlong Ma, Michael Dominic Sacco, Zilei Xia, George Lamprinidis, Julia Alma Townsend, Yanmei Hu, Xiangzhi Meng, Tommy Szeto, Mandy Ba, Xiujun Zhang, Maura Gongora, Fushun Zhang, Michael Thomas Marty, Yan Xiang, Antonios D Kolocouris, Yu Chen, Jun Wang
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay. ACS central science 7 (7) (2021)
Britton Boras, Rhys M Jones, Brandon J Anson, Dan Arenson, Lisa Aschenbrenner, Malina A Bakowski, Nathan Beutler, Joseph Binder, Emily Chen, Heather Eng, Holly Hammond, Jennifer Hammond, Robert E Haupt, Robert L Hoffman, Eugene P Kadar, Rob Kania, Emi Kimito, Melanie G Kirkpatrick, Lorraine Lanyon, Emma K Lendy, Jonathan R Lillis, James P Logue, Suman A Luthra, Chunlong Ma, Stephen W Mason, Marisa E McGrath, Stephen Noell, R Scott Obach, Matthew N O' Brien, Rebecca O'Connor, Kevin Ogilvie, Dafydd Owen, Martin Pettersson, Matthew R Reese, Thomas F Rogers, Romel Rosales, Michelle I Rossulek, Jean G Sathish, Norimitsu Shirai, Claire Steppan, Martyn Ticehurst, Lawrence W Updyke, Stuart M Weston, Yuao Zhu, Kris M White, Adolfo García-Sastre, Jun Wang, Arnab K Chatterjee, Andrew D Mesecar, Matthew B Friemann, Annaliesa S Anderson, Charlotte M N Allerton
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. Nature communications 12 (1) (2021)
Yanmei Hu, Xiangzhi Meng, Fushun Zhang, Yan Xiang, Jun Wang
The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerging microbes & infections 10 (1) (2021)
Chunlong Ma, Jun Wang
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)
Carlos Joaquin Caceres, Yanmei Hu, Stivalis Cárdenas-García, Xiangmeng Wu, Haozhou Tan, Silvia Carnaccini, L Claire Gay, Ginger Geiger, Chunlong Ma, Qing-Yu Zhang, Daniela Rajao, Daniel R Pérez, Jun Wang
Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with in vivo antiviral efficacy against both oseltamivir sensitive and -resistant influenza A viruses. Emerging microbes & infections 10 (1) (2021)
Naoya Kitamura, Michael Dominic Sacco, Chunlong Ma, Yanmei Hu, Julia Alma Townsend, Xiangzhi Meng, Fushun Zhang, Xiujun Zhang, Mandy Ba, Tommy Szeto, Adis Kukuljac, Michael Thomas Marty, David Schultz, Sara Cherry, Yan Xiang, Yu Chen, Jun Wang
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors. Journal of medicinal chemistry (2021)
Britton Boras, Rhys M Jones, Brandon J Anson, Dan Arenson, Lisa Aschenbrenner, Malina A Bakowski, Nathan Beutler, Joseph Binder, Emily Chen, Heather Eng, Holly Hammond, Jennifer Hammond, Robert E Haupt, Robert L Hoffman, Eugene P Kadar, Rob Kania, Emi Kimito, Melanie G Kirkpatrick, Lorraine Lanyon, Emma K Lendy, Jonathan R Lillis, James Logue, Suman A Luthra, Chunlong Ma, Stephen W Mason, Marisa E McGrath, Stephen Noell, R Scott Obach, Matthew N O'Brien Laramy, Rebecca O'Connor, Kevin Ogilvie, Dafydd R Owen, Martin Pettersson, Matthew R Reese, Thomas F Rogers, Michelle I Rossulek, Jean G Sathish, Norimitsu Shirai, Claire M Steppan, Martyn Ticehurst, Lawrence W Updyke, Stuart Weston, Yuao Zhu, Jun Wang, Arnab K Chatterjee, Andrew D Mesecar, Matthew B Frieman, Annaliesa S Anderson, Charlotte Allerton
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19. bioRxiv : the preprint server for biology (2021)
Carlos Joaquin Caceres, Stivalis Cardenas-Garcia, Silvia Carnaccini, Brittany A Seibert, Daniela S Rajao, Jun Wang, Daniel R Pérez
Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model. bioRxiv : the preprint server for biology (2021)
Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses. ACS infectious diseases 7 (3) (2021)
Yanmei Hu, Naoya Kitamura, Rami Musharrafieh, Jun Wang
Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein. Journal of medicinal chemistry 64 (12) (2021)
Chunlong Ma, Yanmei Hu, Julia Alma Townsend, Panagiotis I Lagarias, Michael Thomas Marty, Antonios Kolocouris, Jun Wang
Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors. bioRxiv : the preprint server for biology (2020)
Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang
Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture. bioRxiv : the preprint server for biology (2020)
Jessica L Thomaston, Athina Konstantinidi, Lijun Liu, George Lambrinidis, Jingquan Tan, Martin Caffrey, Jun Wang, William F Degrado, Antonios D Kolocouris
X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance. Biochemistry 59 (4) (2020)
Yanmei Hu, Rami Musharrafieh, Madeleine Zheng, Jun Wang
Enterovirus D68 Antivirals: Past, Present, and Future. ACS infectious diseases 6 (7) (2020)
Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, Peter Dube, Xiujun Zhang, Yanmei Hu, Naoya Kitamura, Brett L Hurst, E Bart Tarbet, Michael Thomas Marty, Antonios Kolocouris, Yan Xiang, Yu Chen, Jun Wang
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L. Science advances 6 (50) (2020)
Chunlong Ma, Yanmei Hu, Jiantao Zhang, Jun Wang
Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68. ACS infectious diseases 6 (8) (2020)
Christina Tzitzoglaki, Kelly McGuire, Panagiotis Lagarias, Athina Konstantinidi, Anja Hoffmann, Natalie A Fokina, Chulong Ma, Ioannis P Papanastasiou, Peter Richard Schreiner, Santiago Vázquez, Michaela Schmidtke, Jun Wang, David D Busath, Antonios D Kolocouris
Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels. ACS chemical biology 15 (9) (2020)
Jiantao Zhang, Yanmei Hu, Nan Wu, Jun Wang
Discovery of Influenza Polymerase PA-PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay. ACS chemical biology 15 (1) (2019)
Chunlong Ma, Yanmei Hu, Jiantao Zhang, Rami Musharrafieh, Jun Wang
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68. ACS infectious diseases 5 (11) (2019)
Jessica L Thomaston, Yibing Wu, Nicholas Polizzi, Lijun Liu, Jun Wang, William F DeGrado
X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case. Journal of the American Chemical Society 141 (29) (2019)
Rami Musharrafieh, Chunlong Ma, Jiantao Zhang, Yanmei Hu, Jessica M Diesing, Michael T Marty, Jun Wang
Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor. Journal of virology 93 (7) (2019)
Rami Musharrafieh, Jiantao Zhang, Peter Tuohy, Naoya Kitamura, Shreya Sai Bellampalli, Yanmei Hu, Rajesh Khanna, Jun Wang
Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68). Journal of medicinal chemistry 62 (8) (2019)
Xin Zhao, Runfeng Li, Yang Zhou, Mengjie Xiao, Chunlong Ma, Zhongjin Yang, Shaogao Zeng, Qiuling Du, Chunguang Yang, Haiming Jiang, Yanmei Hu, Kefeng Wang, Chris Ka Pun Mok, Ping Sun, Jianghong Dong, Wei Cui, Jun Wang, Yaoquan Tu, Zifeng Yang, Wenhui Hu
Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses. Journal of medicinal chemistry 61 (12) (2018)
Yuanxiang Wang, Yanmei Hu, Shuting Xu, Yongtao Zhang, Rami Musharrafieh, Raymond Kin Hau, Chunlong Ma, Jun Wang
In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses. Journal of medicinal chemistry 61 (3) (2018)
Jiantao Zhang, Yanmei Hu, Christopher Foley, Yuanxiang Wang, Rami Musharrafieh, Shuting Xu, Yongtao Zhang, Chunlong Ma, Christopher Hulme, Jun Wang
Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance. Scientific reports 8 (1) (2018)
Jessica L Thomaston, Nicholas F Polizzi, Athina Konstantinidi, Jun Wang, Antonios D Kolocouris, William F DeGrado
Inhibitors of the M2 Proton Channel Engage and Disrupt Transmembrane Networks of Hydrogen-Bonded Waters. Journal of the American Chemical Society 140 (45) (2018)
Yanmei Hu, Jiantao Zhang, Rami Musharrafieh, Raymond Hau, Chunlong Ma, Jun Wang
Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. International journal of molecular sciences 18 (9) (2017)
Fang Li, Yanmei Hu, Yuanxiang Wang, Chunlong Ma, Jun Wang
Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction. Journal of medicinal chemistry 60 (4) (2017)
Marta Barniol-Xicota, Sabrina Gazzarrini, Eva Torres, Yanmei Hu, Jun Wang, Lieve Naesens, Anna Moroni, Santiago Vázquez
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus. Journal of medicinal chemistry 60 (9) (2017)

Jun Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jun Wang